apremilast
Marketedupdated 2mo agoby Annora Pharma Pvt Ltd
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 6 approved and 23 investigational indications.
all catalysts(14)
approval · 14
Mar 21, 2014
approval
OTEZLA (APREMILAST) — FDA approval
apremilast
→
Jul 22, 2014
approval
OTEZLA (APREMILAST) — FDA approval
apremilast
→
Jul 28, 2014
approval
OTEZLA (APREMILAST) — FDA approval
apremilast
→
Sep 19, 2014
approval
OTEZLA (APREMILAST) — FDA approval
apremilast
→
Apr 27, 2015
approval
OTEZLA (APREMILAST) — FDA approval
apremilast
→
Dec 21, 2015
approval
OTEZLA (APREMILAST) — FDA approval
apremilast
→
Jun 29, 2017
approval
OTEZLA (APREMILAST) — FDA approval
apremilast
→
Jul 19, 2019
approval
OTEZLA (APREMILAST) — FDA approval
apremilast
→
Apr 10, 2020
approval
OTEZLA (APREMILAST) — FDA approval
apremilast
→
Dec 20, 2021
approval
OTEZLA (APREMILAST) — FDA approval
apremilast
→
Jul 20, 2023
approval
OTEZLA (APREMILAST) — FDA approval
apremilast
→
Apr 25, 2024
approval
OTEZLA (APREMILAST) — FDA approval
apremilast
→
Jul 23, 2025
approval
OTEZLA (APREMILAST) — FDA approval
apremilast
→
Dec 23, 2025
approval
OTEZLA (APREMILAST) — FDA approval
apremilast
→
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that